Scientists summarize the targeting of CSCs by various immunotherapy strategies such as monoclonal antibodies, tumor vaccines, immune checkpoint inhibitors, and chimeric antigen receptor-T cells in pre-clinical and clinical studies.
[Critical Reviews In Oncology/Hematology]
